Shanghai Bright Meat Group Co., Ltd. (SHA:600073)

Akoya Biosciences Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	22,376	21,896	22,219	24,864	23,536	23,749
Other Revenue	90.77	90.77	148.47	123.74	81.06	117.89
Revenue	22,467	21,987	22,367	24,987	23,617	23,867
Revenue Growth (YoY)	0.77%	-1.70%	-10.49%	5.80%	-1.04%	1.98%
Cost of Revenue	19,991	19,826	20,412	21,754	21,638	21,004
Gross Profit	2,476	2,160	1,955	3,234	1,980	2,862
Selling, General & Admin	1,952	1,952	1,967	1,970	1,771	1,681
Research & Development	64.21	64.33	62.75	50.14	59.36	56.11
Other Operating Expenses	46.41	47.23	50.78	48.62	26.56	28.2
Operating Expenses	2,075	2,075	2,120	2,086	1,853	1,819
Operating Income	400.54	84.96	-164.75	1,148	126.93	1,043
Interest Expense	-158.52	-164.42	-155.9	-127.38	-121.24	-112.11
Interest & Investment Income	164.48	196.42	195.79	177.46	194.64	126.06
Currency Exchange Gain (Loss)	32.12	32.12	28.76	-201.9	23.74	-15.5
Other Non Operating Income (Expenses)	-140.48	8.41	0.59	-19.69	-16.05	-12.82
EBT Excluding Unusual Items	298.14	157.48	-95.51	976.37	208.03	1,029
Impairment of Goodwill	-	-	-	-48.57	-	-105.83
Gain (Loss) on Sale of Investments	26.16	-113.67	-53.3	146.14	-104.08	-28.7
Gain (Loss) on Sale of Assets	81.43	81.16	28.96	-13.45	-6.12	-3.97
Asset Writedown	-51.41	-49.63	-	-	-53.79	-8.46
Other Unusual Items	27.65	27.65	40.58	48.08	88.58	126.77
Pretax Income	381.98	103	-79.27	1,109	132.62	1,009
Income Tax Expense	197.67	114.12	56.04	443.12	234.73	257
Earnings From Continuing Operations	184.31	-11.11	-135.31	665.45	-102.11	751.72
Minority Interest in Earnings	98.12	227.17	360.88	-162.68	404.9	-347.08
Net Income	282.42	216.06	225.57	502.77	302.78	404.64
Net Income to Common	282.42	216.06	225.57	502.77	302.78	404.64
Net Income Growth	127.05%	-4.22%	-55.13%	66.05%	-25.17%	10.55%
Shares Outstanding (Basic)	944	939	940	931	946	941
Shares Outstanding (Diluted)	944	939	940	931	946	941
Shares Change (YoY)	1.82%	-0.05%	0.95%	-1.60%	0.55%	0.26%
EPS (Basic)	0.30	0.23	0.24	0.54	0.32	0.43
EPS (Diluted)	0.30	0.23	0.24	0.54	0.32	0.43
EPS Growth	122.99%	-4.17%	-55.56%	68.75%	-25.58%	10.26%
Free Cash Flow	268.51	403.37	-271.37	1,240	-475.45	1,096
Free Cash Flow Per Share	0.28	0.43	-0.29	1.33	-0.50	1.17
Dividend Per Share	0.070	0.070	0.073	0.161	0.100	0.130
Dividend Growth	-4.11%	-4.11%	-54.66%	61.00%	-23.08%	8.33%
Gross Margin	11.02%	9.83%	8.74%	12.94%	8.38%	11.99%
Operating Margin	1.78%	0.39%	-0.74%	4.59%	0.54%	4.37%
Profit Margin	1.26%	0.98%	1.01%	2.01%	1.28%	1.70%
Free Cash Flow Margin	1.20%	1.84%	-1.21%	4.96%	-2.01%	4.59%
EBITDA	859.08	544.86	300.59	1,590	633.99	1,452
EBITDA Margin	3.82%	2.48%	1.34%	6.36%	2.68%	6.08%
D&A For EBITDA	458.54	459.9	465.34	441.96	507.06	408.26
EBIT	400.54	84.96	-164.75	1,148	126.93	1,043
EBIT Margin	1.78%	0.39%	-0.74%	4.59%	0.54%	4.37%
Effective Tax Rate	51.75%	110.79%	-	39.97%	177.00%	25.48%
Revenue as Reported	22,467	21,987	22,367	24,987	23,617	23,867
Advertising Expenses	-	239.78	187.15	279.83	256.13	286.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.